New therapeutic option has potential to reduce rate of major limb amputation in US
News | Peripheral Artery Disease (PAD)
FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
First dedicated registry to investigate DCB performance in isolated popliteal artery lesions shows Passeo-18 Lux DCB as beneficial treatment for challenging anatomical segment
News | Drug-Eluting Balloons
BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months

September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...

Home September 14, 2023
Home
Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles
News | Cardiovascular Clinical Studies
Myocardial Infarction, the Number One Cause of Sudden Death, May be Treated by Modulating the Immune Response

September 14, 2023 — Myocardial infarction, the number one cause of sudden death in adults and the number two cause of ...

Home September 14, 2023
Home
University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.
News | Cath Lab
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
Socioeconomic status (education, income, employment status and health insurance) appears to be an uneven predictor of heart health with white adults benefitting the most in comparison to Black, Hispanic and Asian Americans
News | Heart Failure
Ohio State Study Shows Socioeconomic Status May Be An Uneven Predictor of Heart Health

September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...

Home September 13, 2023
Home
The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation
News | ECMO Systems
Smidt Heart Institute’s ECMO Expertise Awarded

September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...

Home September 13, 2023
Home
The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months
News | Hypertension
Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

Home September 13, 2023
Home
Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).
News | Cardiovascular Clinical Studies
Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

Home September 12, 2023
Home
Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date
News | Cardiovascular Clinical Studies
Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

Home September 12, 2023
Home
The global interventional cardiology device market is driven by the number of procedures performed across the globe
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD
The New Interventional Cardiology Market

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
Home
UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality
News | Congenital Heart
UCLA Research Suggests that Heart Transplantation is Safer for Adults with Single-ventricle CHD than Previously Thought

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...

Home September 12, 2023
Home
Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL
News | ACC
American College of Cardiology Program to Increase Cholesterol Screenings

September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...

Home September 12, 2023
Home
Videos | Pharmaceuticals
VIDEO, Part 2: Hypertrophic Cardiomyopathy in Focus

In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...

Home September 11, 2023
Home
Premier cardiovascular digital health experience continues cultivating a community to examine and solve for future complex healthcare needs
News | Cardiovascular Business
HRX 2023 Conference Propelling the Future of Digital Health

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

Home September 11, 2023
Home
The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR
News | Drug-Eluting Balloons
MedAlliance Announces Enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease ...

Home September 11, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now